Selenium supplementation in inactive moderate to severe Graves’ orbitopathy patients: a randomized controlled trial-Reference-Cited by-同舟云学术

Selenium supplementation in inactive moderate to severe Graves’ orbitopathy patients: a randomized controlled trial

Published:2024-02-19 Issue:3 Volume:43 Page:329-336
ISSN:0167-6830
Container-title:Orbit
language:en
Short-container-title:Orbit

Author:

Potita Panida¹,Pruksakorn Vannakorn¹^ORCID,Srichomkwun Panudda²,Kingpetch Kanaungnit³,Saonanon Preamjit¹

Affiliation:

1. Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand

2. Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand

3. Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand

Funder

Faculty of Medicine, Chulalongkorn University

Department of ophthalmology, King Chulalongkorn Memorial Hospital

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01676830.2024.2315566

Reference27 articles.

1. Insulin-Like Growth Factor Pathway and the Thyroid

2. Updates on the understanding and management of thyroid eye disease

3. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

4. Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease

5. Selenium and human health

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta‐analysis of randomised controlled trials;Clinical Endocrinology;2024-08-13